Sentimag Magnetic Surgical System for Breast Cancer to be Available in US, Canada

Sentimag Magnetic Surgical System for Breast Cancer to be Available in US, Canada
 Devicor Medical Products, a division of  Leica Biosystems, is now the exclusive United States and Canada distributor of Endomag's magnetic surgical guidance system, Sentimag.  The technology used in Sentimag is heralded as raising the bar for standard of care of breast cancer patients undergoing surgical procedures. Founded in 2007 as a spin-off from the University College London (UCL) and the University of Houston, Cambridge, Endomag sells its products throughout Europe, the Middle East, Africa and Australasia, and is seeking authorization to expand globally. Sentimag, a handheld magnetic probe and the core element of the system, is engineered to detect minuscule amounts of magnetic material in the body, in order to guide surgeons performing lumpectomies using the company's Magseed magnetic tracer product. The product can be placed by radiologists up to 30 days prior to the surgery allowing greater scheduling flexibility for surgeons and radiologists with wire-guided localization. Sentimag can also be used to scan the lymph nodes first in line by using Sienna+, a proprietary, non-toxic, suspension solution of superparamagnetic iron oxide particles injected where the lymphatic system's natural physical action filters out the particles. The sentinel nodes can then be detected in tiny quantities using the Sentimag. This system replaces radioactive tracers and blue dyes used in sentinel lymph node biopsies. Localization can start after only 20 minutes and last up to seven days following injection. Sentimag received European Community authorization in 2010, Sienna+ was authorized in 2011, and has been used in more than 14,000 procedures throughout Europe. Sentimag devices and Sienna tracer are also used in the Caribbean, Hong Kong, Singapore and Aust
Subscribe or to access all post and page content.